18 reports

  • Residential Substance Abuse and Mental Health Facilities Market Characteristics

Pyschiatric Hospitals specialize in the treatment of serious mental disorders such as clinical depression, schizophrenia, and bipolar disorder.

  • Addiction Disorder
  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.
  • EXECUTIVE SUMMARY
  • PRODUCTS AND SERVICES CONTINUED

The most common services provided are the treatment of schizophrenic and psychotic disorders, mood disorders such as depression, mania and bipolar disorder, anxiety disorders and personality disorders.

  • Addiction Disorder
  • Mental Health
  • Canada
  • Demand
  • Forecast
  • Products and services segmentation (2019)
  • Products & Markets

The vast majority of mood disorders are categorized as either depressive disorders or bipolar disorders.

  • Addiction Disorder
  • Mental Health
  • Canada
  • Demand
  • Forecast
  • PRODUCTS & SERVICES CONTINUED

Mood disorders include depressive disorder, dysthymic disorder and bipolar disorder; the NIMH estimates that ##. ##% of Americans over the age of ## suffer from these types of mental illnesses.

  • Addiction Disorder
  • Mental Health
  • Stroke
  • United States
  • Forecast
  • Products & Markets

In addition, individuals with a bipolar disorder (i. e. manic depression) who maintain a regimen of lithium are much less likely to relapse than those not taking the medication.

  • Addiction Disorder
  • Ambulatory Care
  • Mental Health
  • United States
  • Demand

People with family members suffering from schizophrenia and bipolar disorder have a greater disposition to these conditions, and as a result, hereditary mental health problems support sustained demand.

  • Addiction Disorder
  • Mental Health
  • United Kingdom
  • Demand
  • Forecast

THESE STRONG AND VERY IMPORTANT RESULTS TAKES US ONE STEP CLOSER IN REACHING OUR VISION: " IMPROVING THE LIVES OF PEOPLE WITH MENTAL DISORDERS" .

  • Drug Development
  • Healthcare
  • Stroke
  • United States
  • Company
  • Target
  • Clinical Trial profile. 315 Trial Title

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Opioid
  • Stroke
  • World
  • Alkermes plc

Posttraumatic stress disorder (PTSD) is one example.

  • Addiction Disorder
  • Hospital
  • Stroke
  • United States
  • Company

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Pharmaceutical
  • Stroke
  • United States
  • Product Initiative

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Stroke
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • Clinical Trial profile. 216 Trial Title
  • Target

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World
  • Target
  • Clinical Trial profile. 74 Trial Title

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Antiseptics
  • Stroke
  • World
  • Alkermes plc

This makes this project vital in recognizing and correcting control issues for patients with problems like depression and bipolar disorder.

  • Addiction Disorder
  • Hospital
  • Stroke
  • United States
  • Company

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Drug Development
  • Stroke
  • United States
  • MediciNova, Inc.
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd AstraZeneca Plc Acorda Therapeutics Inc Johnson & Johnson Phase IV Phase III/ IV Phase III Phase II/ III Phase II Phase I/ II Phase I TOTAL ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Cardiology
  • Clinical Trial
  • Pharmaceutical
  • Stroke
  • World

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Stroke
  • United States
  • Product Initiative
  • MediciNova, Inc.

SK Biopharmaceuticals Co., Ltd. is developing SKL-PSY for the treatment of depression and bipolar disorder.

  • Addiction Disorder
  • Biopharmaceutical
  • Research And Development
  • Therapy
  • SK Biopharmaceuticals Co., Ltd.